Navigation Links
World's 1st Swine Flu Vaccine Trials Start in Australia
Date:7/22/2009

Washington
636
4
Washington, D.C.
45
 
West Virginia
227
 
Wisconsin
6031
5
Wyoming
106
 
Territories
American Samoa
8
 
'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. BODY WORLDS 2 & Breathe California Pair Up for Some Ash Kicking
2. BODY WORLDS 3 & The Story of the Heart Opens at the California Science Center, March 14, 2008
3. Museum Open Around the Clock - BODY WORLDS 2 and The Tech Host 40 Hour Marathon!
4. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
5. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
6. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
7. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
8. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
9. HHS AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008
10. BODY WORLDS Exhibition Uses Lung Specimens to Launch Anti-Smoking Campaign at the San Diego Natural History Museum
11. Gunther Von Hagens BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Sermo ( http://www.sermo.com ), the world,s ... results of a new Sermo Vitals Report titled ... The report examines physician dialog about diabetes over ... of a variety of topics, including the therapies ... and candid/verbatim comments on issues related to diabetes. ...
(Date:12/16/2009)... WILMINGTON, Delaware, December 16 While ... outsource their accurate forecast models,for new and ... provides,integrated patient-based forecast solutions to various players. ... I, phase II, as well as phase,III. ... launch, product life cycle,management, market entry strategy, ...
(Date:12/16/2009)... Study finds 6- to 11-month interval lessens complication risks , , ... bundle of joy has had such a profound impact on ... take a breath. A new study suggests that you ... pregnant again, and that more than 11 months could be ... interval between pregnancies was less than six months, the chances ...
(Date:12/16/2009)... visitors can earn a free 21-count one week trial bottle sample ... ... MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com announces ... Sample” of Immune Response 247™ 6 Mushroom Formula , with ... Immune Response 247™ 6 Mushroom Formula is packaged in FDA approved ...
(Date:12/16/2009)... The cost of hearing aids has been brought into reach for ... new subscription based hearing plan. , ... (PRWEB) December ... into reach for many Houstonians with the announcement by Hearing Haven, ... benefit by hearing better on the job, and want to improve ...
Breaking Medicine News(10 mins):Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Monthly Subscription Hearing Aid Plan Announced for Houston 2
... Lee Baca has justified placing Paris Hilton under house arrest ... seems that Judge Michael T Sauer who ordered her ... was conning doctors. ,On Larry Kings show, Larry Waldie, ... that Sauer didn't care, and that he even hinted that ...
... Many a families summer vacations mean piling into the car ... marred by frequent nausea and vomiting . This means some ... ,Carsickness, a variant of motion sickness, happens when the ... fast and in what direction the body is moving, says ...
... a clinical stage biopharmaceutical company developing targeted monoclonal ... C virus infection, today announced initiation of ... safety and efficacy of its tumor necrosis therapy ... (GBM), a deadly form of brain cancer. ...
... I trials studying REP8839, a novel topical antibiotic that ... skin pathogens including methicillin-resistant S. aureus (MRSA). ... topically applied REP8839 appears safe, well-tolerated and associated with ... which is desirable for a topical antibiotic treatment. Based ...
... Accera, Inc. announced today that recent data from its Phase ... AD may effectively be thought of and treated as diabetes ... to be caused by the accumulation of amyloid beta plaques ... shown that inducing insulin resistance in the brains of mice ...
... drug, Gatifloxacin, is a better treatment for drug- resistant ... a team of researchers led by Dr Buddha Basnyat ... ,As part of the study, researchers compared the effect ... recommended by the World Health Organisation for treating enteric ...
Other Medicine News:Health News:Car Sickness for the Little Ones can Be Prevented 2Health News:Car Sickness for the Little Ones can Be Prevented 3Health News:Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial 2Health News:Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839 2Health News:Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain 2
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Inc. (Nasdaq: BLUD ), a global leader in ... today announced that it will release its fiscal 2010 ... the market close. The Company will host a conference ... (Eastern Time) to discuss the results. ,, ... by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also access ...
(Date:12/15/2009)... -- Robbins & Myers, Inc. (NYSE: RBN ... its fiscal 2010 first quarter ending November 30, 2009, ... A live webcast is scheduled for ... Peter C. Wallace, President and Chief Executive Officer, ... Officer, will be discussing the Company,s performance and responding ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 1Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 2Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 345 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 145 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 2Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2
... Suggest Potential for Treating Motor System Disorders, ... novel small,molecule currently in clinical development by TorreyPines ... of acute migraine headache, was shown,in an independent ... muscle,spasticity and rigidity in a rat model of ...
... European Trial Opening in 13 New Sites, ... GNTA ) announced that the French Health ... the Company,s,Phase 3 trial of Genasense(R) (oblimersen sodium) ... melanoma. This authorization,enables the opening of approximately 13 ...
Other Medicine Technology:Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 2Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 3Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 4Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 2Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 3
... aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand ... Volume Range (ul) ... 1.0~2.0 Imprecision(%) ... 1 ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
Medicine Products: